EGS Beteiligungen AG increases stake in Siegfried Holding AG to 6.2% registered shares via bond conversion.
EGS Beteiligungen AG has converted a bond into shares, increasing its stake in Siegfried Holding AG to 6.2% registered shares (7.2% including purchase position). The move follows Siegfried's acquisition of two pharmaceutical sites in Spain, where EGS participated in financing. Siegfried, a global life sciences company with 12 sites across 3 continents, achieved CHF 1.272 billion in sales in 2023.
June 14, 2024
3 Articles